Tetralogic Pharmaceuticals Corp Company Profile (NASDAQ:TLOG)

About Tetralogic Pharmaceuticals Corp

Tetralogic Pharmaceuticals Corp logoTetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TLOG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.06
  • 50 Day Moving Average: $0.0689
  • 200 Day Moving Average: $0.1233
  • 52-Week Range: $0.03 - $0.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.06
  • P/E Growth: 0.0000
  • Market Cap: $1.42M
  • Outstanding Shares: 24,769,000
  • Beta: 3
Profitability:
  • Return on Assets: -81.56%
Debt:
  • Debt-to-Equity Ratio: -1.00%
  • Current Ratio: 0.48%
  • Quick Ratio: 0.48%
Additional Links:
Companies Related to Tetralogic Pharmaceuticals Corp:

Analyst Ratings

Consensus Ratings for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
Show:
DateFirmActionRatingPrice TargetDetails
1/7/2016Roth CapitalLower Price TargetBuy$5.00 -> $1.00View Rating Details
5/7/2015Needham & Company LLCLower Price TargetBuy$10.00 -> $7.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2015Q414($0.39)($0.53)$1.13 millionViewN/AView Earnings Details
11/5/2014Q314($4.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
Current Year EPS Consensus Estimate: $-1.7700 EPS
Next Year EPS Consensus Estimate: $-0.9900 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.37)($0.37)($0.37)
Q2 20161($0.21)($0.21)($0.21)
Q3 20161($0.22)($0.22)($0.22)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
Insider Ownership Percentage: 24.00%
Institutional Ownership Percentage: 2.69%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell333,630$0.17$56,717.10View SEC Filing  
2/5/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell1,415,490$0.18$254,788.20View SEC Filing  
2/2/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell369,132$0.19$70,135.08View SEC Filing  
1/28/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell311,930$0.28$87,340.40View SEC Filing  
7/10/2015Andrew L PecoraDirectorBuy50,000$2.68$134,000.00View SEC Filing  
7/9/2015Andrew L PecoraDirectorBuy50,000$2.40$120,000.00View SEC Filing  
7/2/2015Paul J SchmittDirectorBuy10,000$2.34$23,400.00View SEC Filing  
3/27/2015Pete A MeyersCFOBuy5,000$4.35$21,750.00View SEC Filing  
3/26/2015J Kevin BuchiCEOBuy5,000$4.23$21,150.00View SEC Filing  
1/7/2015J Kevin BuchiCEOBuy5,000$5.04$25,200.00View SEC Filing  
12/10/2014Colin Glenn BegleySVPBuy5,900$6.16$36,344.00View SEC Filing  
12/9/2014J Kevin BuchiCEOBuy5,000$6.01$30,050.00View SEC Filing  
12/4/2014Pete A MeyersCFOBuy1,034$4.94$5,107.96View SEC Filing  
12/2/2014J Kevin BuchiCEOBuy10,000$4.99$49,900.00View SEC Filing  
11/26/2014Colin Glenn BegleySVPBuy3,100$4.86$15,066.00View SEC Filing  
11/26/2014Lesley RussellCOOBuy20,000$4.90$98,000.00View SEC Filing  
11/25/2014Colin Glenn BegleySVPBuy2,000$4.85$9,700.00View SEC Filing  
11/18/2014J Kevin BuchiCEOBuy10,000$4.82$48,200.00View SEC Filing  
11/17/2014Andrew L PecoraDirectorBuy20,000$4.53$90,600.00View SEC Filing  
11/12/2014Peter A MeyersCFOBuy5,000$3.98$19,900.00View SEC Filing  
11/11/2014J Kevin BuchiCEOBuy10,000$3.93$39,300.00View SEC Filing  
11/10/2014Paul J SchmittDirectorBuy20,000$4.10$82,000.00View SEC Filing  
12/17/2013J Kevin BuchiCEOBuy285,714$7.00$1,999,998.00View SEC Filing  
12/17/2013James N WoodyDirectorBuy261,427$7.00$1,829,989.00View SEC Filing  
12/17/2013Peter A MeyersCFOBuy142,857$7.00$999,999.00View SEC Filing  
12/17/2013Ventures Vii Lp HealthcareMajor ShareholderBuy713,463$7.00$4,994,241.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
DateHeadline
News IconTrading Scope: ADX and CCI Review for Tetralogic Pharmaceuticals Corp (TLOG) - Sherwood Daily (NASDAQ:TLOG)
sherwooddaily.com - February 2 at 6:05 AM
News IconTrading Scope: ADX and CCI Review for Tetralogic Pharmaceuticals Corp (TLOG) - Sherwood Daily (NASDAQ:TLOG)
sherwooddaily.com - February 2 at 6:05 AM
News IconIs This Stock Ready to Rumble: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Prospect Journal (NASDAQ:TLOG)
prospectjournal.com - January 28 at 7:06 AM
News IconAre There Any Catalysts to Propel This Stock Forward: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Prospect Journal (NASDAQ:TLOG)
prospectjournal.com - January 27 at 6:15 AM
News IconWilliams %R, RSI, and ADX Update for Tetralogic Pharmaceuticals Corp (TLOG) - Sherwood Daily (NASDAQ:TLOG)
sherwooddaily.com - January 27 at 6:15 AM
News IconMonitoring Relative Strength Index Values for Tetralogic Pharmaceuticals Corp (TLOG) - Sherwood Daily (NASDAQ:TLOG)
sherwooddaily.com - January 21 at 3:31 AM
News IconIs There a Catalyst Out There For TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Prospect Journal (NASDAQ:TLOG)
prospectjournal.com - January 21 at 3:31 AM
4-traders.com logoTetraLogic Pharmaceuticals : Announces Director Appointment (NASDAQ:TLOG)
www.4-traders.com - January 19 at 5:04 AM
News IconAnalysts Projecting Upside, Can This Stock Surge Higher: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Prospect Journal (NASDAQ:TLOG)
prospectjournal.com - January 16 at 7:59 PM
News IconTetraLogic Pharmaceuticals Corporation (OTC:TLOG) Closed the Last Trading Session at $0.1 - The Newburgh Press (NASDAQ:TLOG)
newburghpress.com - January 11 at 6:36 AM
News IconQuarterly Financial Watch for TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (NASDAQ:TLOG)
flapship.com - January 5 at 7:07 AM
News IconStocks Making Notable Moves: Marinus Pharmaceuticals (NASDAQ ... - Street Wise Report (press release) (blog) (NASDAQ:TLOG)
streetwisereport.com - January 2 at 7:58 PM
wallstrt24.com logoStock's Buzzers Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Tetralogic Pharmaceuticals Corp (OTCMKTS:TLOG) - Wall Street 24 (NASDAQ:TLOG)
wallstrt24.com - January 2 at 7:58 PM
4-traders.com logoTetraLogic Pharmaceuticals : Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB (NASDAQ:TLOG)
www.4-traders.com - December 31 at 7:59 PM
News IconA Keen Look at These Shares: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Prospect Journal (NASDAQ:TLOG)
prospectjournal.com - December 31 at 1:53 AM
directorstalkinterviews.com logoTetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets ... - DirectorsTalk Interviews (NASDAQ:TLOG)
www.directorstalkinterviews.com - December 31 at 1:53 AM
News IconTetralogic Pharmaceuticals Corp (OTCMKTS:TLOG) Is Running Up, But What's Next? - Insider Financial (NASDAQ:TLOG)
www.insiderfinancial.com - December 31 at 1:53 AM
bizjournals.com logoTetraLogic completes $12M asset sale to Swedish drug developer (NASDAQ:TLOG)
www.bizjournals.com - December 31 at 1:52 AM
finance.yahoo.com logoMedivir Completes Previously Announced Oncology Programs Acquisition (NASDAQ:TLOG)
finance.yahoo.com - December 29 at 8:12 PM
streetinsider.com logoForm 8-K IMPAX LABORATORIES INC For: Dec 19 - StreetInsider.com (NASDAQ:TLOG)
www.streetinsider.com - December 20 at 8:48 PM
News IconTetraLogic Pharmaceuticals Corporation (TLOG) Under Analyst Spotlight - UK Market News (NASDAQ:TLOG)
www.ukmarketnews.co.uk - December 15 at 6:43 AM
News IconTetraLogic Pharmaceuticals Corporation (TLOG) Valuation According To Analysts - UK Market News (NASDAQ:TLOG)
www.ukmarketnews.co.uk - December 2 at 7:47 PM
News IconCCI Level Check for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 26 at 9:55 AM
News IconFollowing the Charts on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 24 at 7:50 PM
News IconTechnical Analysis Focus: RSI Watch for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 23 at 8:05 PM
News IconChart Watch: Following Indicators on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 22 at 12:39 PM
biz.yahoo.com logoTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to (NASDAQ:TLOG)
biz.yahoo.com - November 22 at 12:39 PM
News IconStock Watch: Indicators in View for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 21 at 8:25 PM
News IconBroker Review: TetraLogic Pharmaceuticals Corporation (TLOG) - UK Market News (NASDAQ:TLOG)
www.ukmarketnews.co.uk - November 17 at 7:36 PM
News IconWatching CCI and RSI levels on Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 17 at 7:36 PM
News IconStock Concentration on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 15 at 8:43 PM
News IconStock Spotter: Review on Technical Levels for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 15 at 11:42 AM
biz.yahoo.com logoTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements (NASDAQ:TLOG)
biz.yahoo.com - November 14 at 8:09 PM
News IconTraders are Keeping Track of Technicals on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 11 at 7:39 PM
News IconMA Levels in Review for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 10 at 7:55 PM
News IconWilliams %R Check on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 10 at 11:28 AM
News IconQuick Review on Trend Indicator Levels: Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 8 at 7:50 PM
finance.yahoo.com logoTETRALOGIC PHARMACEUTICALS CORP Financials (NASDAQ:TLOG)
finance.yahoo.com - November 8 at 7:50 PM
News IconTechnical Focus: What's Happening With Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 7 at 12:04 PM
News IconShares Knocked Down Over Past Month: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - CSZ News (NASDAQ:TLOG)
cincysportszone.com - November 5 at 10:05 AM
News IconTechnical Toolbox: Investor Focus on Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 5 at 10:05 AM
bizjournals.com logo$12M deal: Malvern biopharm firm sells assets to Swedish drug developer (NASDAQ:TLOG)
www.bizjournals.com - November 4 at 7:30 PM
News IconStocks Weigh Momentum on Experts Views- TetraLogic Pharmaceuticals (NASDAQ:TLOG), Jazz Pharmaceuticals ... - Street Wise Report (press release) (blog) (NASDAQ:TLOG)
streetwisereport.com - November 4 at 11:57 AM
streetinsider.com logoTetraLogic Pharma (TLOG) Announces Same of SMAC Mimetic Program; Will Move to Delist Stock (NASDAQ:TLOG)
www.streetinsider.com - November 3 at 7:55 PM
biz.yahoo.com logoTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Costs Associated with (NASDAQ:TLOG)
biz.yahoo.com - November 3 at 7:55 PM
News IconFocusing on the Numbers for Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 3 at 12:13 PM
News IconTrading Scope: Following Levels on Shares of Tetralogic Pharmaceuticals Corp (TLOG) - MicroCap Wired (NASDAQ:TLOG)
www.microcapwired.com - November 2 at 8:21 PM
streetinsider.com logoTetraLogic Pharma (TLOG) Announces Same of SMAC Mimetic Program; Will Move to Delist Stock - StreetInsider.com (NASDAQ:TLOG)
www.streetinsider.com - November 2 at 8:21 PM
uk.finance.yahoo.com logoMedivir Strengthens Its Clinical Pipeline by Entering into Agreement to Acquire a Portfolio of Clinical Stage Oncology Programs (NASDAQ:TLOG)
uk.finance.yahoo.com - November 2 at 8:20 PM
publicnow.com logoTetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock (NASDAQ:TLOG)
www.publicnow.com - November 2 at 8:20 PM

Social

What is Tetralogic Pharmaceuticals Corp's stock symbol?

Tetralogic Pharmaceuticals Corp trades on the NASDAQ under the ticker symbol "TLOG."

How do I buy Tetralogic Pharmaceuticals Corp stock?

Shares of Tetralogic Pharmaceuticals Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Tetralogic Pharmaceuticals Corp stock cost?

One share of Tetralogic Pharmaceuticals Corp stock can currently be purchased for approximately $0.06.

Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)

Earnings History Chart

Earnings by Quarter for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)

Dividend History Chart

Dividend Payments by Quarter for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)

Last Updated on 2/20/2017 by MarketBeat.com Staff